Nanoparticles are defined as solid colloidal particles ranging in size from 10 to 1000 nm. Nanoparticles offer many benefits to larger particles such as increased surface-to-volume ratio and increased magnetic properties. Over the last few years, there has been a steadily growing interest in using nanoparticles in different biomedical applications such as targeted drug delivery, hyperthermia, photoablation therapy, bioimaging and biosensors. Iron oxide nanoparticles have dominated applications, such as drug delivery, hyperthermia, bioimaging, cell labelling and gene delivery, because of their excellent properties such as chemical stability, non-toxicity, biocompatibility, high saturation magnetisation and high magnetic susceptibility. In this review, nanoparticles will be classified into four different nanosystems metallic nanoparticles, bimetallic or alloy nanoparticles, metal oxide nanoparticles and magnetic nanoparticles. This review investigates the use of nanosystems other than iron oxide nanoparticles such as metallic nanoparticles like gold (Au) and silver (Ag), bimetallic nanoparticles like iron cobalt (Fe-Co) and iron platinum (Fe-Pt) and metal oxides including titanium dioxide (TiO2) cerium dioxide (CeO2), silica (SiO2) and zinc oxide (ZnO) with a focus on the lesser studied nanoparticles such as silver (Ag), iron-platinum (Fe-Pt) and titanium dioxide (TiO2) and how their unique properties allow for their potential use in various biomedical applications.
29 May 2015 in Physical Chemistry Chemical Physics
There is a growing interest in the use of nanosystems in biomedical applications. In this perspective, we survey current applications and advances in magnetic nanoparticles used in biomedical applications, so as to understand the material properties that can pave the way for the use of nanoalloys.
The electrochemical performance of Ge, an alloying anode in the form of directly grown nanowires (NWs), in Li-ion full cells (vs LiCoO2) was analyzed over a wide temperature range (−40 to 40 °C). LiCoO2||Ge cells in a standard electrolyte exhibited specific capacities 30× and 50× those of LiCoO2||C cells at −20 and −40 °C, respectively. We further show that propylene carbonate addition further improved the low-temperature performance of LiCoO2||Ge cells, achieving a specific capacity of 1091 mA h g–1 after 400 cycles when charged/discharged at −20 °C. At 40 °C, an additive mixture of ethyl methyl carbonate and lithium bis(oxalato)borate stabilized the capacity fade from 0.22 to 0.07% cycle–1. Similar electrolyte additives in LiCoO2||C cells did not allow for any gains in performance. Interestingly, the capacity retention of LiCoO2||Ge improved at low temperatures due to delayed amorphization of crystalline NWs, suppressing complete lithiation and high-order Li15Ge4 phase formation. The results show that alloying anodes in suitably configured electrolytes can deliver high performance at the extremes of temperature ranges where electric vehicles operate, conditions that are currently not viable for commercial batteries without energy-inefficient temperature regulation.